Taiwan to boost biotech R&D and product lines
This article was originally published in Clinica
Taiwan is to boost its biotechnology translational research with greater investment and infrastructure development. Taiwan's deputy health minister Dr Yen-jen Sung, made the commitment at the APEC Biotechnology Conference in Taipei last month, according to the Taipei Times. The move is to safeguard the region against the potential risks of global epidemics, such as the SARS outbreak in 2003. The first priority would be to attract more researchers and develop research infrastructure, said Mr Sung, followed by the promotion of tech transfer, and the commercialisation of newly-developed products. He said that the government would be financing research in the field.